Hydrogel-based tissue engineering scaffolds are widely used for culturing cells in three dimensions (3D) due to their tissue-like water content, tunable biochemical and physical properties, and ease of cell encapsulation and distribution in 3D.
Researchers in Dr. Shatz's lab have identified murine PirB and its human ortholog LilrB2 as receptors for β-amyloid (Aβ) oligomers. Aβ oligomers play a central role in a number of pathologies.
Rechargeable lithium sulfur batteries have attracted great interest in recent years because of their high theoretical specific energy, which is several times that of current lithium-ion batteries.
A team of Stanford researchers have identified a novel small molecule that could be used in vivo or ex vivo to enrich for submandibular salivary gland (SMG) stem cell (SC).
Stanford researchers have developed a versatile molecular engineering approach, via random copolymerization, to gain good processability while maintaining high charge transport and photovoltaic performance for conjugated copolymers.
Researchers in Dr. Roeland Nusse's lab have developed a mouse monoclonal antibody to ROR2 (Nt 2535-2835). ROR2 is a membrane bound receptor tyrosine kinase that is activated by non-canonical Wnt signaling through its association with Wnt5.
This invention provides a novel strategy for depolymerizing polyesters and polycarbonates with alcohols through the use of nucleophilic N-heterocyclic carbenes as catalysts.
Homodyne image reconstruction is combined with an iterative decomposition of water and fat from MR signals obtained from a partial k-space signal acquisition in order to maximize the resolution of calculated water and fat images.
Disclosed is x-ray cone beam scan data reconstruction of an imaged object with a reconstruction algorithm using shift invariant filtering and backprojection with the maximum tomographic capability of a circular scan larger than p plus cone angle, when CB data is not truncated
Researchers in Prof. Karl Deisseroth's laboratory have developed specific, inducible animal models for depression that use targeted optogenetic strategies to precisely dissect the neuronal circuits underlying the condition.
Researchers in Prof. Robert Malenka's laboratory have developed a light-activated animal system that could be used to identify compounds that treat certain psychiatric disorders.
Researchers in Prof. Karl Deisseroth's laboratory have developed a system to enhance optogenetic pumps using one tool to address current limitations in both inhibition and excitation.